PEG-IFN-beta (Toray)

聚乙二醇干扰素β (东丽)

Report date: 2022/01/25 17:54:55

Base Information

Drug NamePEG-IFN-beta (Toray)
Drug Alias NamePEGylated-interferon betaPEG-IFN-betaPeginterferon-betaPEG-interferon-betaTRK-560
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesToray Industries Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesToray Industries Inc
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A